DEBORAH J ANDREWS
CIK 1325697 · Interim Co-CEO and CFO · last filed 2026-07-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$274.3K
Companies
3
Total Filings
55
Lifetime Open-Market Net
-$6.82M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 2 of 6
55 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-30 | LCTX | Mixed | +5,578 | -$1.7K | EDGAR |
| 2020-07-02 | LCTX | Grant (A) | — | $0 | EDGAR |
| 2020-03-24 | STAA | Sell (S) | −834 | -$22.9K | EDGAR |
| 2020-01-23 | STAA | Mixed | — | -$3.31M | EDGAR |
| 2019-11-15 | STAA | Sell (S) | −4,167 | -$144.5K | EDGAR |
| 2019-07-03 | — | Grant (A) | — | $0 | |
| 2019-04-05 | STAA | Sell (S) | −1,000 | -$34.4K | EDGAR |
| 2019-03-22 | STAA | Sell (S) | −833 | -$32.4K | EDGAR |
| 2019-03-15 | STAA | Grant (A) | — | $0 | EDGAR |
| 2018-09-13 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Buy (P) | +1,604 | $3.8K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.